-
Something wrong with this record ?
Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition
J. Remšík, L. Binó, Z. Kahounová, G. Kharaishvili, Š. Šimecková, R. Fedr, T. Kucírková, S. Lenárt, XM. Muresan, E. Slabáková, L. Knopfová, J. Bouchal, M. Král, P. Beneš, K. Soucek,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NV15-33999A
MZ0
CEP Register
NV15-28628A
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Source
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
Medline Complete (EBSCOhost)
from 1996-01-01 to 1 year ago
PubMed
30010814
DOI
10.1093/carcin/bgy095
Knihovny.cz E-resources
- MeSH
- Antigens, Neoplasm genetics metabolism MeSH
- Antigens, CD biosynthesis MeSH
- Epithelial-Mesenchymal Transition physiology MeSH
- Epithelial Cells metabolism MeSH
- Cadherins biosynthesis MeSH
- Carcinoma pathology MeSH
- Humans MeSH
- DNA Methylation genetics MeSH
- Cell Adhesion Molecules genetics metabolism MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Cell Line, Tumor MeSH
- Prostatic Neoplasms mortality pathology MeSH
- Breast Neoplasms mortality pathology MeSH
- Disease Progression MeSH
- Xenograft Model Antitumor Assays MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The cell surface glycoprotein Trop-2 is commonly overexpressed in carcinomas and represents an exceptional antigen for targeted therapy. Here, we provide evidence that surface Trop-2 expression is functionally connected with an epithelial phenotype in breast and prostate cell lines and in patient tumor samples. We further show that Trop-2 expression is suppressed epigenetically or through the action of epithelial-to-mesenchymal transition transcription factors and that deregulation of Trop-2 expression is linked with cancer progression and poor patient prognosis. Moreover, our data suggest that the cancer plasticity-driven intratumoral heterogeneity in Trop-2 expression may significantly contribute to response and resistance to therapies targeting Trop-2-expressing cells.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028321
- 003
- CZ-PrNML
- 005
- 20241217090038.0
- 007
- ta
- 008
- 190813s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/carcin/bgy095 $2 doi
- 035 __
- $a (PubMed)30010814
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Remšík, Ján $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition / $c J. Remšík, L. Binó, Z. Kahounová, G. Kharaishvili, Š. Šimecková, R. Fedr, T. Kucírková, S. Lenárt, XM. Muresan, E. Slabáková, L. Knopfová, J. Bouchal, M. Král, P. Beneš, K. Soucek,
- 520 9_
- $a The cell surface glycoprotein Trop-2 is commonly overexpressed in carcinomas and represents an exceptional antigen for targeted therapy. Here, we provide evidence that surface Trop-2 expression is functionally connected with an epithelial phenotype in breast and prostate cell lines and in patient tumor samples. We further show that Trop-2 expression is suppressed epigenetically or through the action of epithelial-to-mesenchymal transition transcription factors and that deregulation of Trop-2 expression is linked with cancer progression and poor patient prognosis. Moreover, our data suggest that the cancer plasticity-driven intratumoral heterogeneity in Trop-2 expression may significantly contribute to response and resistance to therapies targeting Trop-2-expressing cells.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a CD antigeny $x biosyntéza $7 D015703
- 650 _2
- $a antigeny nádorové $x genetika $x metabolismus $7 D000951
- 650 _2
- $a nádory prsu $x mortalita $x patologie $7 D001943
- 650 _2
- $a kadheriny $x biosyntéza $7 D015820
- 650 _2
- $a karcinom $x patologie $7 D002277
- 650 _2
- $a molekuly buněčné adheze $x genetika $x metabolismus $7 D015815
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a metylace DNA $x genetika $7 D019175
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a epitelové buňky $x metabolismus $7 D004847
- 650 _2
- $a epitelo-mezenchymální tranzice $x fyziologie $7 D058750
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a nádory prostaty $x mortalita $x patologie $7 D011471
- 650 _2
- $a xenogenní modely - testy protinádorové aktivity $7 D023041
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Binó, Lucia $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. $7 xx0326742
- 700 1_
- $a Kahounová, Zuzana $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Kharaishvili, Gvantsa $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Šimecková, Šárka $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Fedr, Radek $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Kucírková, Tereza $u Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Lenárt, Sára $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Muresan, Ximena Maria $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 700 1_
- $a Slabáková, Eva $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Knopfová, Lucia $u Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Bouchal, Jan $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Král, Milan $u Department of Urology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Beneš, Petr $u Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Soucek, Karel $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Center of Biomolecular and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
- 773 0_
- $w MED00001050 $t Carcinogenesis $x 1460-2180 $g Roč. 39, č. 11 (2018), s. 1411-1418
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30010814 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20241217090035 $b ABA008
- 999 __
- $a ok $b bmc $g 1433470 $s 1066781
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 39 $c 11 $d 1411-1418 $e 20181213 $i 1460-2180 $m Carcinogenesis $n Carcinogenesis $x MED00001050
- GRA __
- $a NV15-33999A $p MZ0
- GRA __
- $a NV15-28628A $p MZ0
- LZP __
- $a Pubmed-20190813